Cost effectiveness model comparing trimethoprim sulfamethoxazole and ciprofloxacin for the treatment of chronic bacterial prostatitis

European Urology

Volumn 42, Issue 2, 2002, Pages 163-166

  Kurzer, Elie ^a   Kaplan, Steven A ^b  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b Columbia University ^*  (United States)

Author keywords

Chronic bacterial prostatitis; Ciprofloxacin; Economic modeling; Trimethoprim sulfamethoxazole

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CHRONIC BACTERIAL PROSTATITIS; CHRONIC PROSTATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; HEALTH CARE COST; HUMAN; MALE; MODEL; PARAMETER; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME; BACTERIAL INFECTION; CHRONIC DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; PROBABILITY; PROSTATITIS; STATISTICAL MODEL;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CHRONIC DISEASE; CIPROFLOXACIN; COST-BENEFIT ANALYSIS; DRUG COSTS; HEALTH CARE COSTS; HUMAN; MALE; MARKOV CHAINS; MODELS, ECONOMIC; PROSTATITIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; HUMANS;

EID: 0036668367     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00270-1     Document Type: Article

References (15)

1. A community based study on the prevalence of prostatitis
2. How common is prostatitis? A national survey of physician visits
3. Sickness impact of chronic nonbacterial prostatitis and its correlates
4. Bacteriologic localization pattern in bacterial prostatitis and urethritis
5. Trimethoprim-sulfamethoxazole and minocycline-hydrochloride in the treatment of cutlure proved bacterial prostatitis
6. Long term therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole
7. Recurrent urinary tract infections in men
8. Bacterial prostatitis
9. Serum antibody titers in treatment with trimethoprim-sulfamethoxazole for chronic prostatitis
10. Treatment of chronic bacterial prostatitis with ciprofloxacinfloxacin
11. Ciprofloxacinfloxacin in the treatment of chronic bacterial prostatitis: A prospective, non-comparative multicentre clinical trial with long term follow up
12. Refractory chronic bacterial prostatitis: A reevaluation of ciprofloxacinfloxacin treatment after a median follow up of 30 months
13. Outcome of antibiotic therapy with ciprofloxacinfloxacin in chronic bacterial prostatitis
14. Treatment of chronic bacterial prostatitis with ciprofloxacin
15. Chronic prostatitis: Current concepts and antimicrobial therapy